Elekta wins USD 35 million tender in China

Press Release
Stockholm, Sweden, August 30, 2012

Elekta has won a major tender where the Health Department of the People’s
Liberation Army (PLA) is expanding its capacity to treat cancer.

Cancer is one of the leading causes of death in China, according to the Earth
Policy Institute, and with an aging population, the number of cancer patients is
forecasted to grow significantly in the coming years. The PLA, which manages the
military hospitals, is addressing the challenge presented by the high incidence
and mortality of cancer by awarding a public tender to Elekta for the purchase
of cancer management solutions.

Elekta will deliver a comprehensive range of clinical solutions, including
Leksell Gamma Knife® as well as linear accelerators and associated software. The
total value of the contract amounts to some USD 35 million, making it Elekta’s
largest deal ever in China. The order will be booked when all conditions in the
tender have been finalized.

Gilbert Wai, Executive Vice President, Region Asia Pacific says: “By partnering
with Elekta, the PLA hospitals will help more cancer patients to receive the
treatment they need in their battle with cancer. This deal is the latest in many
with the PLA, demonstrating the great faith it has in Elekta and our products.
It also strengthens Elekta’s number one position in the Chinese market.”

Elekta has been present in China since 1982 and is now the company’s third
largest market. “Our commitment to improving access to high quality cancer
treatment and management goes beyond selling products,” says Wai. “As a
comprehensive solutions partner in China, Elekta helps with clinical
implementation as well as education and training services.”

******

Contact:

Johan Andersson Melbi, Investor Relations Manager, Elekta AB
+46 702 100 451, johan.anderssonmelbi@elekta.com

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07.30 CET on August 30, 2012.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,300 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb.